Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
- DOI
- 10.1016/j.intimp.2020.107205
- Published
- 2021-01
- Container
- International Immunopharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.intimp.2020.107205,
title = {Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial},
author = {Payam Tabarsi and Saghar Barati and Hamidreza Jamaati and Sara Haseli and Majid Marjani and Afshin Moniri and Zahra Abtahian and Alireza Dastan and Sahar Yousefian and Raha Eskandari and Ali Saffaei and Fatemeh Monjazebi and Abdolbaset Vahedi and Farzaneh Dastan},
year = {2021},
journal = {International Immunopharmacology},
doi = {10.1016/j.intimp.2020.107205},
url = {https://doi.org/10.1016/j.intimp.2020.107205}
}RIS
TY - JOUR TI - Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial AU - Payam Tabarsi AU - Saghar Barati AU - Hamidreza Jamaati AU - Sara Haseli AU - Majid Marjani AU - Afshin Moniri AU - Zahra Abtahian AU - Alireza Dastan AU - Sahar Yousefian AU - Raha Eskandari AU - Ali Saffaei AU - Fatemeh Monjazebi AU - Abdolbaset Vahedi AU - Farzaneh Dastan PY - 2021 JO - International Immunopharmacology DO - 10.1016/j.intimp.2020.107205 UR - https://doi.org/10.1016/j.intimp.2020.107205 ER -
APA
Tabarsi, P., Barati, S., Jamaati, H., Haseli, S., Marjani, M., Moniri, A., Abtahian, Z., Dastan, A., Yousefian, S., Eskandari, R., Saffaei, A., Monjazebi, F., Vahedi, A., & Dastan, F. (2021). Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2020.107205
Source records
- crossref · retrieved 2026-09-27T01:23:10.552Z